Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 accelerates SARS‐CoV‐2 clearance: A single‐center propensity score‐matched cohort study

Song et al., Journal of Medical Virology, doi:10.1002/jmv.28805

May 2023

PSM analysis of 65 HH-120 patients and 103 controls contemporaneously hospitalized in the same hospital, showing faster viral clearance with HH-120 treatment, with improved results for patients with higher baseline viral load.

Important missing comments or errors? Let us know.

time to viral-, 20.0% lower, relative time 0.80, p = 0.001, treatment 65, control 103, propensity score matching.

time to viral-, 28.6% lower, relative time 0.71, p = 0.001, higher baseline viral load, propensity score matching.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Song et al., 25 May 2023, retrospective, China, peer-reviewed, 13 authors, study period 3 August, 2022 - 7 October, 2022.

This Paper HH-120 All

Late treatment
is less effective

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0